AI English summary of an SEC filing — figures as filed
Cardinal Health CAHThe company said it completed a public offering of notes due 2026 at 4.700% totaling $500,000,000, notes due 2029 at 5.000% totaling $750,000,000, notes due 2034 at 5.350% totaling $1,000,000,000, and notes due 2054 at 5.750% totaling $650,000,000 on November 22, 2024.
Key points
AI summaryThe company said it completed a public offering of notes due 2026 at 4.700% totaling $500,000,000, notes due 2029 at 5.000% totaling $750,000,000, notes due 2034 at 5.350% totaling $1,000,000,000, and notes due 2054 at 5.750% totaling $650,000,000 on November 22, 2024.
Cardinal Health said it intends to use the net proceeds from the note sale to fund part of the consideration for its acquisition of a majority of the equity interests in The GI Alliance Holdings, LLC (the GIA Acquisition) and its acquisition of Advanced Diabetes Supply Group, along with related fees and expenses.
The company said it will be required to redeem all of the notes at 101% of their principal amount, plus accrued and unpaid interest, if the GIA Acquisition is not completed by November 11, 2025 (the End Date) or as otherwise specified, or if it notifies the trustee that it will not pursue the GIA Acquisition.
The company said it terminated the excess commitments that remained outstanding under its $2.9 billion 364-day senior unsecured bridge term loan facility with Bank of America, N.A., after the commitments were reduced dollar for dollar by the net cash proceeds from the notes offering. It delivered the termination notice on November 22, 2024.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Completes 4-Tranche Notes Offering
The company said it completed a public offering of notes due 2026 at 4.700% totaling $500,000,000, notes due 2029 at 5.000% totaling $750,000,000, notes due 2034 at 5.350% totaling $1,000,000,000, and notes due 2054 at 5.750% totaling $650,000,000 on November 22, 2024.
Source · Based on the filing body and exhibits
Use of Net Proceeds
Cardinal Health said it intends to use the net proceeds from the note sale to fund part of the consideration for its acquisition of a majority of the equity interests in The GI Alliance Holdings, LLC (the GIA Acquisition) and its acquisition of Advanced Diabetes Supply Group, along with related fees and expenses.
Source · Based on the filing body and exhibits
Special Mandatory Redemption Terms
The company said it will be required to redeem all of the notes at 101% of their principal amount, plus accrued and unpaid interest, if the GIA Acquisition is not completed by November 11, 2025 (the End Date) or as otherwise specified, or if it notifies the trustee that it will not pursue the GIA Acquisition.
Source · Based on the filing body and exhibits
Termination of Excess Bridge Loan Commitments
The company said it terminated the excess commitments that remained outstanding under its $2.9 billion 364-day senior unsecured bridge term loan facility with Bank of America, N.A., after the commitments were reduced dollar for dollar by the net cash proceeds from the notes offering. It delivered the termination notice on November 22, 2024.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…